Table 4.

Probabilities of relapse and relapse-free survival among CML and AL patients, divided into early (CR1/CP1) and late (> CR1/CP1) disease

No.Relapse (2 y), %DFS (2 y), %
PBSC    
 CML early disease 39 64  
 CML late disease 12 21 45  
 AL early disease 17 68 
 AL late disease 37 57 25  
Bone marrow    
 CML early disease 42 70  
 CML late disease 10 38 40  
 AL early disease 18 21 64 
 AL late disease 36 57 26 
No.Relapse (2 y), %DFS (2 y), %
PBSC    
 CML early disease 39 64  
 CML late disease 12 21 45  
 AL early disease 17 68 
 AL late disease 37 57 25  
Bone marrow    
 CML early disease 42 70  
 CML late disease 10 38 40  
 AL early disease 18 21 64 
 AL late disease 36 57 26 

DFS indicates disease-free survival.

or Create an Account

Close Modal
Close Modal